Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer - Université de Bourgogne Accéder directement au contenu
Article Dans Une Revue Breast Cancer Research and Treatment Année : 2011

Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer

Dates et versions

hal-00821764 , version 1 (12-05-2013)

Identifiants

Citer

Alexandre Cochet, Gaetan Quilichini, Inna Dygai-Cochet, Claude Touzery, Michel Toubeau, et al.. Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer. Breast Cancer Research and Treatment, 2011, 130 (3), pp.845-854. ⟨10.1007/s10549-011-1714-9⟩. ⟨hal-00821764⟩
144 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More